Aavik E - Search Results

1

Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.

Guse K, Dias JD, Bauerschmitz GJ, Hakkarainen T, Aavik E, Ranki T, Pisto T, Särkioja M, Desmond RA, Kanerva A, Hemminki A. Guse K, et al. Among authors: aavik e. Gene Ther. 2007 Jun;14(11):902-11. doi: 10.1038/sj.gt.3302949. Epub 2007 Mar 22. Gene Ther. 2007. PMID: 17377596

2

Correlation between gene expression and morphological alterations in baboon carotid after balloon dilatation injury.

Aavik E, Mahapatra A, Boldrick J, Chen X, Barry C, Dutoit D, Sarwal M, Häyry P. Aavik E, et al. FASEB J. 2005 Jan;19(1):130-2. doi: 10.1096/fj.04-2225fje. Epub 2004 Oct 20. FASEB J. 2005. PMID: 15496494

3

Immunobiology and pathology of chronic rejection.

Häyry P, Myllärniemi M, Calderon Ramirez L, Aavik E, Loubtchenkov M, Koskinen P, Lemström K, Räisänen-Sokolowski A. Häyry P, et al. Among authors: aavik e. Transplant Proc. 1997 Feb-Mar;29(1-2):77-8. doi: 10.1016/s0041-1345(96)00014-0. Transplant Proc. 1997. PMID: 9123163 Review. No abstract available.

4

Molecular biology of transplant arteriosclerosis and sites of therapeutic intervention.

Häyry P, Aavik E, Palgi M, Petrov L, Savolainen H, Luoto NM, Loubtchenkov M, Frösen J. Häyry P, et al. Among authors: aavik e. Transplant Proc. 2001 Feb-Mar;33(1-2):293-4. doi: 10.1016/s0041-1345(00)02014-5. Transplant Proc. 2001. PMID: 11266824 No abstract available.

5

Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat.

Häyry P, Myllärniemi M, Aavik E, Alatalo S, Aho P, Yilmaz S, Räisänen-Sokolowski A, Cozzone G, Jameson BA, Baserga R. Häyry P, et al. Among authors: aavik e. FASEB J. 1995 Oct;9(13):1336-44. doi: 10.1096/fasebj.9.13.7557024. FASEB J. 1995. PMID: 7557024

6

Chronic allograft rejection.

Häyry P, Myllärniemi M, Aavik E. Häyry P, et al. Among authors: aavik e. Transplant Proc. 1996 Aug;28(4):2337-8. Transplant Proc. 1996. PMID: 8769244 Review. No abstract available.

7

Blockade of growth factor synthesis and growth factor action: two possible sites of interference in allograft vessel disease and coronary bypass or balloon injury.

Häyry P, Aavik E, Myllärniemi M. Häyry P, et al. Among authors: aavik e. Metabolism. 1996 Aug;45(8 Suppl 1):101-3. doi: 10.1016/s0026-0495(96)90097-9. Metabolism. 1996. PMID: 8769397

8

Chronic rejection: potential new sites of therapy.

Häyry P, Myllärniemi M, Aavik E, Lemström K, Koskinen P. Häyry P, et al. Among authors: aavik e. Transplant Proc. 1996 Dec;28(6):3225-6. Transplant Proc. 1996. PMID: 8962248 Review. No abstract available.

9

Role of growth factors in graft vessel disease.

Häyry P, Myllärniemi M, Aavik E, Loubtschenkov M, Ramirez LC. Häyry P, et al. Among authors: aavik e. Transplant Proc. 1997 Sep;29(6):2551. doi: 10.1016/s0041-1345(97)00502-2. Transplant Proc. 1997. PMID: 9290736 No abstract available.

10

Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta.

Mäkelä S, Savolainen H, Aavik E, Myllärniemi M, Strauss L, Taskinen E, Gustafsson JA, Häyry P. Mäkelä S, et al. Among authors: aavik e. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7077-82. doi: 10.1073/pnas.96.12.7077. Proc Natl Acad Sci U S A. 1999. PMID: 10359841 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page